MedAxiom has been acquired by American College of Cardiology
The private shareholders of MedAxiom have sold the company to American College of Cardiology, Inc.
MedAxiom was founded in 2001 and is the nation’s leading cardiovascular performance community serving physician practices by providing expert consulting, networking and membership services including data analytics, program excellence tools and educational events to improve business and patient care outcomes.
American College of Cardiology is a trade association that caters to cardiovascular professionals to learn, grow and share knowledge about cardiovascular care and heart health. It also reviews and offers certification courses focusing on cardiovascular diseases. The association helps in the formation of cardiology guidelines, clinical data standards and health policies. Additionally, it publishes cardiovascular journals which focus on cardiovascular diseases, including original clinical studies, translational investigations with clear clinical relevance, state-of-the-art papers, review articles, and editorials interpreting and commenting on the research presented. American College of Cardiology was founded in 1949 and is based in Washington, DC.
Oaklins’ teams in Jacksonville and Savannah acted as financial advisors to MedAxiom in this transaction.
Jennifer Linville
Founding CEO, MedAxiom
Talk to the deal team
Related deals
CARSO Group has acquired a majority stake in AQCF Group
CARSO Group, a leading provider of testing services, has acquired a majority stake in AQCF Group, a key player in the field of food safety.
Learn morePrestige Inhome Care has found a long-term strategic partner
Prestige Inhome Care has received a growth capital investment from Yorkway Private. The newly formed partnership will provide growth capital for geographic expansion, increasing Prestige’s range of services and potential future acquisitions. The investment in Prestige is in line with Yorkway’s mandate to invest in leading Australian mid-market companies with strong management teams, backed by significant growth tail winds, as is the case in the aged care industry.
Learn moreCara Care has been acquired by Mahana Therapeutics
Mahana Therapeutics Inc., renowned for its pioneering digital treatments targeting chronic health issues, has recently finalized the acquisition of Cara Care (HiDoc Technologies GmbH). Cara Care stands out as a premier digital health platform and an official digital health application (DiGA) dedicated to enhancing gut health. This acquisition, supported by key investors Lux Capital and Jazz Ventures Partners, perfectly aligns with Mahana’s expansion strategy.
Learn more